Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device

American Journal of Cardiology

Volumn 96, Issue 1, 2005, Pages 67-70

  Rha, Seung Woon ^a   Kuchulakanti, Pramod K ^a   Pakala, Rajbabu ^a   Cheneau, Edouard ^a   Pinnow, Ellen ^a   Torguson, Rebecca ^a   Pichard, Augusto D ^a   Satler, Lowell F ^a   Suddath, William O ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HIRULOG;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EMBOLISM; FALSE ANEURYSM; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; ISCHEMIA; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBINS; CORONARY ARTERIOSCLEROSIS; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS; THROMBOSIS; TREATMENT OUTCOME;

EID: 20744456941     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.02.047     Document Type: Article

References (11)

1. J.A. Bittl, J. Strony, J.A. Brinker, W.H. Ahmed, C.R. Meckel, B.R. Chaitman, J. Maraganore, E. Deutsch, B. Adelman Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina N Engl J Med 333 1995 764 769
2. J.A. Bittl, B.R. Chaitman, F. Feit, W. Kimball, E.J. Topol Bivalirudin Angioplasty Study Investigators Bivalirudin vs heparin during coronary angioplasty for unstable or post-infarction angina; final report reanalysis of the Bivalirudin Angioplasty Study Am Heart J 142 2001 952 959
3. R. Wolfram, L. Leborgne, E. Cheneau, E.E. Pinnow, D.A. Canos, D. Hellinga, L.F. Satler, A.D. Pichard, K.M. Kent, R. Waksman Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention Am J Cardiol 92 2003 1080 1083
4. M.K. Hong, R. Mehran, G. Dangas, G.S. Mintz, A.J. Lansky, A.D. Pichard, K.M. Kent, L.F. Satler, G.W. Stone, M.B. Leon Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality Circulation 100 1999 2400 2405
5. M.K. Hong, R. Mehran, G. Dangas, G.S. Mintz, A. Lansky, K.M. Kent, A.D. Pichard, L.F. Satler, G.W. Stone, M.B. Leon Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results J Am Coll Cardiol 38 2001 150 154
6. D.R. Holmes Jr, E.J. Topol, R.M. Califf, L.G. Berdan, F. Leya, P.B. Berger, P.L. Whitlow, R.D. Safian, A.G. Adelman, M.A. Kellett Jr CAVEAT-II Investigators A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions Circulation 91 1995 1966 1974
7. A.M. Lincoff, J.A. Bittl, R.A. Harrington, F. Feit, N.S. Kleiman, J.D. Jackson, I.J. Sarembock, D.J. Cohen, D. Spriggs, R. Ebrahimi REPLACE-2 Investigators Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention REPLACE-2 Randomized Trial JAMA 289 2003 853 863
8. A.M. Lincoff, J.A. Bittl, N.S. Kleiman, I.J. Sarembock, J.D. Jackman, S. Mehta, M.A. Tannenbaum, A.L. Niederman, W.B. Bachinsky, J. Tift-Mann III REPLACE-1 Investigators Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the REPLACE-1 trial) Am J Cardiol 93 2004 1092 1096
9. G.W. Stone, C. Rogers, J. Hermiller, R. Feldman, P. Hall, R. Haber, A. Masud, P. Cambier, R.P. Caputo, M. Turco FilterWire EX Randomized Evaluation Investigators Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts Circulation 108 2003 548 553
10. D.S. Baim, D. Wahr, B. George, M.B. Leon, J. Greenberg, D.E. Cutlip, U. Kaya, J.J. Popma, K.K. Ho, R.E. Kuntz Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators Randomized trial of a distal protection device during percutaneous intervention of saphenous vein aorto-coronary bypass graft Circulation 105 2002 1285 1290
11. A.K. Rao, C. Pratt, A. Berke, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, M.L. Terrin Thrombolysis In Myocardial Infarction (TIMI) trial, phase I hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11